Traverse Energy (TVETF) 0.3160 $TVETF Traverse Energy

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Traverse Energy (TVETF) 0.3160 $TVETF

Traverse Energy Ltd. Closes Brokered Private Placement
Marketwire Canada - Fri May 27, 12:04PM CDT
CALGARY, ALBERTA--(Marketwired - May 27, 2016) - Traverse Energy Ltd. (the "Corporation" (TSX VENTURE:TVL) announces that it has closed its previously announced brokered private placement (the "Private Placement" of common shares issued as "flow-through shares" (the "Shares" under the Income Tax Act (Canada) (the "Tax Act". Acumen Capital Finance Partners Limited (the "Agent" acted as the sole and exclusive agent of the Corporation in the Private Placement.
TVL.VN: 0.440 (+0.040)

Traverse Energy Announces 2016 First Quarter Results
Marketwire Canada - Mon May 16, 3:25PM CDT
CALGARY, ALBERTA--(Marketwired - May 16, 2016) - Traverse Energy Ltd. ("Traverse" or "the Company" (TSX VENTURE:TVL) presents financial and operating results for the three months ended March 31, 2016.
TVL.VN: 0.440 (+0.040)

Traverse Energy Ltd. Grants Stock Options
Marketwired - Tue Apr 26, 3:44PM CDT
Traverse Energy Ltd. (the "Corporation" (TSX VENTURE: TVL) announces that it granted stock options to its directors and officers to purchase 1,250,000 common shares with an exercise price of $0.36 per share and an expiry date 5 years from the date of grant. The options vest immediately upon grant. The total number of options outstanding as of the date hereof is 7,175,000.
TVL.VN: 0.440 (+0.040)

Traverse Energy Announces 2015 Year End Results
Marketwire Canada - Thu Apr 14, 3:41PM CDT
Traverse Energy Ltd. ("Traverse" or "the Company" (TSX VENTURE:TVL) presents financial and operating results for the year ended December 31, 2015.
TVL.VN: 0.440 (+0.040)

Traverse Energy Ltd. Announces Normal Course Issuer Bid
Marketwired - Wed Mar 16, 3:10PM CDT
Traverse Energy Ltd. (the "Corporation" (TSX VENTURE: TVL) is pleased to announce that the TSX Venture Exchange (the "TSXV" has accepted the notice filed by the Corporation of its intention to make a normal course issuer bid through the facilities of the TSXV.
TVL.VN: 0.440 (+0.040)

Traverse Energy Announces 2015 Year End Reserves
Marketwired - Mon Mar 14, 4:12PM CDT
Traverse Energy Ltd. ("Traverse" or "the Company" (TSX VENTURE: TVL) presents its 2015 year-end reserves. Traverse's independent reserve report was prepared by Sproule Associates Limited ("Sproule" in accordance with National Instrument 51-101 effective December 31, 2015.
TVL.VN: 0.440 (+0.040)

Traverse Energy Announces 2015 Third Quarter Results
Marketwired - Mon Nov 16, 4:53PM CST
Traverse Energy Ltd. ("Traverse" or "the Company" (TSX VENTURE: TVL) presents financial and operating results for the nine months ended September 30, 2015.
TVL.VN: 0.440 (+0.040)

Traverse Energy Ltd. Closes Private Placement Financing
Marketwired - Thu Oct 29, 4:35PM CDT
Traverse Energy Ltd. (the "Corporation" (TSX VENTURE: TVL) is pleased to announce that it has successfully closed its previously announced non-brokered private placement (the "Private Placement" of common shares of the Corporation ("Shares" issued on a "flow through" basis eligible for the renunciation of Canadian development expenses within the meaning of the Income Tax Act (Canada). The Corporation issued 1,168,000 Shares for gross proceeds of $700,800. The Shares issued are subject to a hold period under applicable securities laws until March 1, 2016.
TVL.VN: 0.440 (+0.040)

Traverse Energy Ltd. Announces Increase in Size of Private Placement Financing
Marketwired - Mon Oct 19, 3:56PM CDT
Traverse Energy Ltd. (the "Corporation" (TSX VENTURE: TVL) reports that due to the oversubscription of its previously announced non-brokered private placement, the Corporation is increasing the size of its private placement of common shares of the Corporation ("Shares" to be issued on a "flow through" basis eligible for the renunciation of Canadian development expenses within the meaning of the Income Tax Act (Canada) at $0.60 per Share (the "Private Placement". The Corporation will now issue up to 1,168,000 Shares for total gross proceeds of up to $700,800. In addition, the Corporation will pay a finder's fee on a portion of the Private Placement consisting of a cash payment equal to 5% of the gross proceeds raised from certain subscriptions.
TVL.VN: 0.440 (+0.040)

Traverse Energy Ltd. Announces Private Placement Financing
Marketwired - Tue Oct 13, 3:14PM CDT
Traverse Energy Ltd. (the "Corporation" (TSX VENTURE: TVL) intends to complete a non-brokered private placement (the "Private Placement" of up to of 1,000,000 common shares of the Corporation ("Shares" to be issued on a "flow through" basis eligible for the renunciation of Canadian development expenses within the meaning of the Income Tax Act (Canada) at $0.60 per Share for total gross proceeds of $600,000.
TVL.VN: 0.440 (+0.040)

Traverse Energy Announces Horizontal Drilling Results
Marketwired - Mon Aug 24, 3:43PM CDT
Traverse Energy Ltd. (the "Company" (TSX VENTURE: TVL) has placed on production another horizontal well in the Coyote area. This well was drilled in an Upper Mannville zone previously delineated by wells drilled in the deeper Coyote Ellerslie pool. The well was drilled to a total measured depth of 2,510 metres, including a 1,140 horizontal section and was fracture treated in 22 stages. The well was initially swabbed and flowed for cleanup and production testing. During the test a total of 1,150 barrels of oil and 3.9 mmcf of raw natural gas were produced over a 6 day period.
TVL.VN: 0.440 (+0.040)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading